Buy Daslemia 70 Dasatinib

Daslemia 70 (dasatinib 70mg) is an oral prescription medication used for certain blood cancers. It belongs to the tyrosine kinase inhibitor class and comes in 60-tablet packs for daily use. This product is stored at room temperature and requires a prescription.

Strength

70mg

Pack Size

60s

Storage

Ambient

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Daslemia 70 is prescribed to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) in specific patient groups. It works by targeting abnormal proteins that cause uncontrolled cell growth. Patients prescribed Daslemia 70 often have Philadelphia chromosome-positive conditions. This medication is part of targeted therapy approaches for blood cancers.

Side Effects

Daslemia 70 may help reduce cancer cell growth and improve blood cell counts in some patients. Users often report improved energy levels and reduced symptoms related to their condition over time. Individual responses vary based on medical history and treatment plans. Regular monitoring is typically required during therapy.

Precautions & Warnings

Keep Daslemia 70 in its original packaging away from moisture and direct sunlight. Store at room temperature as indicated on the label. Always handle with clean, dry hands and avoid crushing or splitting tablets unless directed. Keep out of reach of children and pets. Consult a healthcare provider for proper disposal methods.

Avoid Interactions

Daslemia 70 can interact with other medications, including certain antibiotics, antifungals, and heart medications. Grapefruit products may affect how the body processes this drug. Always inform your doctor about all prescription, over-the-counter, and herbal products you use. Some interactions may require dose adjustments or monitoring.

References

Frequently Asked Questions

Daslemia 70 is used to treat certain types of blood cancers, including chronic myeloid leukemia and acute lymphoblastic leukemia.

Store Daslemia 70 at room temperature in its original packaging away from moisture and direct light.

Consult your doctor before combining Daslemia 70 with any other prescription, over-the-counter, or herbal products.

Yes, Daslemia 70 is a prescription medication and requires authorization from a licensed healthcare provider.

If you miss a dose, contact your healthcare provider for guidance rather than taking extra medication.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.